Thyroid carcinoma is rare among human malignancies (<1%) but is the most frequent endocrine cancer, accounting for about 5% of thyroid nodules (1). The latter are very frequent in the general population and, according to the method of detection and the age of the patients, their prevalence may approach 20–50% of the general population, thus representing a daily issue in endocrine clinics. Furthermore, the incidence of thyroid cancer, mainly differentiated, is one of the most rapidly increasing human cancers, at least in the United States (2), with the papillary histotype being the most frequent (nearly 80%). There is a need for uniform diagnostic and treatment strategies for thyroid nodules and differentiated thyroid cancer (DT...
Differentiated thyroid cancer ( DTC ) is usually not very common ( incidence is about 1 % of all can...
From thyroid nodules to thyroid cancer Abstract. The prevalence of thyroid nodules is around 1 % per...
Objective Thyroid cancer incidence is increasing. The rise is most pronounced for microcancers (≤10 ...
Thyroid carcinoma is rare among human malignancies (<1%) but is the most frequent endocrine cancer, ...
The incidence of thyroid cancer has been increasing in many countries over the last 30 years (from 3...
Objective: To assess approaches to patients with a potentially malignant thyroid nodule and patients...
OBJECTIVE: To assess approaches to patients with a potentially malignant thyroid nodule and patients...
© 2014, Serbian Medical Society. All rights reserved. Differentiated thyroid carcinomas (DTCs) prese...
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is beco...
The incidence of thyroid cancer has been increasing in many countries over the last 30 years (from 3...
Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new...
AbstractIntroductionThis study describes the experience of a tertiary care hospital in the managemen...
- Differentiated thyroid carcinoma is a rare disease. Appropriate diagnosis, treatment and follow-up...
The incidence of differentiated thyroid cancers has increased in the past 30 years, mainly due to ov...
Thyroid cancer is the most common endocrine malignancy, although representing fewer than 1% of all h...
Differentiated thyroid cancer ( DTC ) is usually not very common ( incidence is about 1 % of all can...
From thyroid nodules to thyroid cancer Abstract. The prevalence of thyroid nodules is around 1 % per...
Objective Thyroid cancer incidence is increasing. The rise is most pronounced for microcancers (≤10 ...
Thyroid carcinoma is rare among human malignancies (<1%) but is the most frequent endocrine cancer, ...
The incidence of thyroid cancer has been increasing in many countries over the last 30 years (from 3...
Objective: To assess approaches to patients with a potentially malignant thyroid nodule and patients...
OBJECTIVE: To assess approaches to patients with a potentially malignant thyroid nodule and patients...
© 2014, Serbian Medical Society. All rights reserved. Differentiated thyroid carcinomas (DTCs) prese...
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is beco...
The incidence of thyroid cancer has been increasing in many countries over the last 30 years (from 3...
Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new...
AbstractIntroductionThis study describes the experience of a tertiary care hospital in the managemen...
- Differentiated thyroid carcinoma is a rare disease. Appropriate diagnosis, treatment and follow-up...
The incidence of differentiated thyroid cancers has increased in the past 30 years, mainly due to ov...
Thyroid cancer is the most common endocrine malignancy, although representing fewer than 1% of all h...
Differentiated thyroid cancer ( DTC ) is usually not very common ( incidence is about 1 % of all can...
From thyroid nodules to thyroid cancer Abstract. The prevalence of thyroid nodules is around 1 % per...
Objective Thyroid cancer incidence is increasing. The rise is most pronounced for microcancers (≤10 ...